Case Report: Medial prefrontal syndrome in a coup de sabre scleroderma carrier
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.contributor.author | Sanguino-Caneva, Ciro | |
| dc.contributor.author | Carrillo-Chapman, Carlos | |
| dc.contributor.author | Luque-Llano, Melissa | |
| dc.contributor.author | Bermúdez, Valmore | |
| dc.contributor.author | Vargas-Manotas, José | |
| dc.date.accessioned | 2025-07-07T22:01:55Z | |
| dc.date.available | 2025-07-07T22:01:55Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Introduction: Linear scleroderma en coup de sabre is a subtype of scleroderma hallmarked by cutaneous and extracutaneous manifestations in which neurological symptoms can be a predominant feature of this condition. Case presentation: We report a case of a previously healthy 47-year old male who developed neuropsychiatric symptoms and right-sided cephalalgia for two months. Clinical examination revealed a right frontoparietal cutaneous lesion and neurological findings suggesting a medial prefrontal syndrome. The neuroimaging evaluation identified scalp and bone thinning adjacent to the skin lesion and cortical subcortical white matter hyperintensity due to vasogenic oedema at the right frontal and parietal region. A biopsy from the affected area revealed reactive gliosis. Conclusion: To our knowledge, this is the first linear scleroderma en coup de sabre report associated with a neurological involvement typical of a medial prefrontal syndrome. This case highlights the importance of clinical acuity in recognising atypical phenotypes within the spectrum of this uncommon disease. | eng |
| dc.format.mimetype | ||
| dc.identifier.citation | Sanguino-Caneva C, Carrillo-Chapman C, Luque-Llano M et al. Case Report: Medial prefrontal syndrome in a coup de sabre scleroderma carrier [version 1; peer review: 1 approved with reservations, 1 not approved] F1000Research 2023, 12:1254 https://doi.org/10.12688/f1000research.141188.1 | spa |
| dc.identifier.doi | https://doi.org/10.12688/f1000research.141188.1 | |
| dc.identifier.issn | 20461402 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/16804 | |
| dc.identifier.url | https://f1000research.com/articles/12-1254/v1 | |
| dc.language.iso | eng | eng |
| dc.publisher | Taylor and Francis | eng |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | F1000Research | spa |
| dc.source | Vol. 12 No. 1254, (2023) | spa |
| dc.subject.keywords | Localized Scleroderma | eng |
| dc.subject.keywords | Linear Scleroderma en coup de sabre | eng |
| dc.subject.keywords | Morphea | eng |
| dc.subject.keywords | Neurologic involvement | eng |
| dc.subject.keywords | Neurologic manifestations | eng |
| dc.subject.keywords | Prefrontal syndrome | eng |
| dc.title | Case Report: Medial prefrontal syndrome in a coup de sabre scleroderma carrier | eng |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.spa | Artículo científico | |
| dcterms.references | Denton CP, Khanna D: Systemic sclerosis. Lancet. 2017 Oct 7; 390(10103): 1685–1699. Epub 2017 Apr 13. | eng |
| dcterms.references | Rongioletti F, Ferreli C, Atzori L, et al.: Scleroderma with an update about clinico-pathological correlation. G. Ital. Dermatol. Venereol. 2018 Apr; 153(2): 208–215. Epub 2018 Jan 24. | eng |
| dcterms.references | Medsger TA Jr, Masi AT: Epidemiology of systemic sclerosis (scleroderma). Ann. Intern. Med. 1971 May; 74(5): 714–721. | eng |
| dcterms.references | Zhong L, Pope M, Shen Y, et al.: Prevalence and incidence of systemic sclerosis: A systematic review and meta-analysis. Int. J. Rheum. Dis. 2019 Dec; 22(12): 2096–2107. Epub 2019 Oct 16. | eng |
| dcterms.references | Tian J, Kang S, Zhang D, et al.: Global, regional, and national incidence and prevalence of systemic sclerosis. Clin. Immunol. 2023 Mar; 248: 109267. Epub 2023 Feb 15. | eng |
| dcterms.references | Careta MF, Romiti R: Localized scleroderma: clinical spectrum and therapeutic update. An. Bras. Dermatol. 2015 Jan-Feb; 90(1): 62–73. | eng |
| dcterms.references | Peterson LS, Nelson AM, Su WP, et al.: The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J. Rheumatol. 1997 Jan; 24(1): 73–80. | eng |
| dcterms.references | Snarskaya ES, Vasileva KD: Localized scleroderma: actual insights and new biomarkers. Int. J. Dermatol. 2022 Jun; 61(6): 667–674. Epub 2021 Aug 4. | eng |
| dcterms.references | Pinho J, Rocha J, Sousa F, et al.: Localized scleroderma en coup de sabre in the Neurology Clinic. Mult. Scler. Relat. Disord. 2016 Jul; 8: 96–98. Epub 2016 May 20. | eng |
| dcterms.references | Pierre-Louis M, Sperling LC, Wilke MS, et al.: Distinctive histopathologic findings in linear morphea (en coup de sabre) alopecia. J. Cutan. Pathol. 2013 Jun; 40(6): 580–584. Epub 2013 Mar 18 | eng |
| dcterms.references | Lis-Święty A, Skrzypek-Salamon A, Ranosz-Janicka I, et al.: Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences. J. Eur. Acad. Dermatol. Venereol. 2017 Oct; 31(10): 1595–1603. Epub 2017 Apr 3. | eng |
| dcterms.references | Mertens JS, Seyger MM, Kievit W, et al.: Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. Br. J. Dermatol. 2015 Mar; 172(3): 722–728. Epub 2015 Feb 8. | eng |
| dcterms.references | Mazori DR, Wright NA, Patel M, et al.: Characteristics and treatment of adult-onset linear morphea: A retrospective cohort study of 61 patients at 3 tertiary care centers. J. Am. Acad. Dermatol. 2016 Mar; 74(3): 577–579. | eng |
| dcterms.references | Yamasaki R, Yonekawa T, Inamizu S, et al.: A case of overlapping adult-onset linear scleroderma and Parry-Romberg syndrome presenting with widespread ipsilateral neurogenic involvement. Neuropathology. 2020 Feb; 40(1): 109–115. Epub 2019 Nov 27 | eng |
| dcterms.references | García Martos Á, González Gómez FJ, Terrancle JI: Stroke-mimic and scleroderma in “coup de sabre”: Case report. Rev Colomb Reumatol Engl Ed. 2021; 28(4): 306–308 | eng |
| dcterms.references | Amaral TN, Peres FA, Lapa AT, et al.: Neurologic involvement in scleroderma: a systematic review. Semin. Arthritis Rheum. 2013 Dec; 43(3): 335–347. Epub 2013 Jul 1. | eng |
| dcterms.references | Gambichler T, Kreuter A, Hoffmann K, et al.: Bilateral linear scleroderma “en coup de sabre” associated with facial atrophy and neurological complications. BMC Dermatol. 2001; 1: 9. Epub 2001 Dec 4. | eng |
| dcterms.references | Sarria-Estrada S, Toledo M, Santamarina E, et al.: Esclerosis mesial temporal en un caso de esclerodermia lineal en coup de sabre. Rev. Neurol. 2011; 53(05): 316. | eng |
| dcterms.references | Chung MH, Sum J, Morrell MJ, et al.: Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann. Neurol. 1995 May; 37(5): 679–681. | eng |
| dcterms.references | Magro CM, Halteh P, Olson LC, et al.: Linear scleroderma “en coup de sabre” with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy. Orphanet J. Rare Dis. 2019 May 16; 14(1): 110. | eng |
| dcterms.references | Nguyen K, Atty C, Ree A: Linear scleroderma en coup de sabre presenting with seizures. Radiol Case Rep. 2020 Sep 3; 15(11): 2164–2170. | spa |
| dcterms.references | Kister I, Inglese M, Laxer RM, et al.: Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology. 2008 Nov 4; 71(19): 1538–1545. | eng |
| dcterms.references | Stone J, Franks AJ, Guthrie JA, et al.: Scleroderma “en coup de sabre”: pathological evidence of intracerebral inflammation. J. Neurol. Neurosurg. Psychiatry. 2001 Mar; 70(3): 382–385. | eng |
| dcterms.references | Takahashi T, Asano Y, Oka T, et al.: Scleroderma en coup de sabre with recurrent episodes of brain hemorrhage. J. Dermatol. 2016 Feb; 43(2): 203–206. Epub 2015 Jul 15 | eng |
| dcterms.references | Corbally CM, Breckenridge A, Jampana R: Imaging and clinical findings in a case of linear scleroderma en coup de sabre. BJR Case Rep. 2016 Nov 2; 2(4): 20150203. | eng |
| dcterms.references | Miura S, Someya M, Toyama S, et al.: A case of scleroderma en coup de sabre with ipsilateral hearing loss and aphakia. Eur. J. Dermatol. 2019 Aug 1; 29(4): 423–425. | eng |
| dcterms.references | Hock LE, Kontzialis M, Szewka AJ: Linear scleroderma en coup de sabre presenting with positional diplopia and enophthalmos. Neurology. 2016 Oct 18; 87(16): 1741–1742. | eng |
| dcterms.references | Rimoin L, Arbiser J: Improvement of “En Coup de Sabre” Morphea and Associated Headaches With Botulinum Toxin Injections. Dermatol. Surg. 2016 Oct; 42(10): 1216–1219. | eng |
| dcterms.references | Infante-Valenzuela A, Camara-Lemarroy CR, Delgado-Garcia G, et al.: Steroid-responsive headache in scleroderma en coup de sabre. Acta Neurol. Belg. 2017 Mar; 117(1): 405–407. Epub 2016 Jul 18. | eng |
| dcterms.references | Doolittle DA, Lehman VT, Schwartz KM, et al.: CNS imaging findings associated with Parry-Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities. Neuroradiology. 2015 Jan; 57(1): 21–34. Epub 2014 Oct 11. | eng |
| dcterms.references | Appenzeller S, Montenegro MA, Dertkigil SS, et al.: Neuroimaging findings in scleroderma en coup de sabre. Neurology. 2004 May 11; 62(9): 1585–1589. | eng |
| dcterms.references | Lis-Święty A, Brzezińska-Wcisło L, Arasiewicz H: Neurological abnormalities in localized scleroderma of the face and head: a case series study for evaluation of imaging findings and clinical course. Int. J. Neurosci. 2017 Sep; 127(9): 835–839. Epub 2016 Oct 26 | eng |
| dcterms.references | Hixon AM, Christensen E, Hamilton R, et al.: Epilepsy in Parry-Romberg syndrome and linear scleroderma en coup de sabre: Case series and systematic review including 140 patients. Epilepsy Behav. 2021 Aug; 121(Pt A): 108068. Epub 2021 May 28. | eng |
| dcterms.references | Papara C, De Luca DA, Bieber K, et al.: Morphea: The 2023 update. Front Med (Lausanne). 2023 Feb 13; 10: 1108623. | eng |
| dcterms.references | Kurzinski K, Torok KS: Cytokine profiles in localized scleroderma and relationship to clinical features. Cytokine. 2011 Aug; 55(2): 157–164. Epub 2011 May 4. | eng |
| dcterms.references | Taniguchi T, Asano Y, Tamaki Z, et al.: Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases. J. Eur. Acad. Dermatol. Venereol. 2014 Dec; 28(12): 1805–1810. Epub 2013 Oct 10. | eng |
| dcterms.references | Asano Y, Fujimoto M, Ishikawa O, et al.: Diagnostic criteria, severity classification and guidelines of localized scleroderma. J. Dermatol. 2018 Jul; 45(7): 755–780. Epub 2018 Apr 23 | eng |
| dcterms.references | Knobler R, Moinzadeh P, Hunzelmann N, et al.: European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J. Eur. Acad. Dermatol. Venereol. 2017 Sep; 31(9): 1401–1424. Epub 2017 Aug 9. | eng |
| dcterms.references | Mertens JS, Marsman D, van de Kerkhof PC , et al.: Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate. Acta Derm. Venereol. 2016 May; 96(4): 510–513. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | |
| sb.programa | Especialización en Neurología | spa |
| sb.sede | Sede Barranquilla | spa |